Brazil Pharmaceuticals Market Summary, Competitive Analysis and Forecast to 2027
Brazil Pharmaceuticals Market Summary, Competitive Analysis and Forecast to 2027
Summary
Pharmaceuticals in Brazil industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2017-22, and forecast to 2027). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
Summary
Pharmaceuticals in Brazil industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2017-22, and forecast to 2027). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
- The Brazilian pharmaceuticals market had total revenues of $20.4 billion in 2022, representing a negative compound annual growth rate (CAGR) of 7.4% between 2017 and 2022.
- 0
- R&D expenditure in Brazil is only 0.49% of GDP, below the OECD average of 2.67%.
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the pharmaceuticals market in Brazil
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Brazil
- Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Brazil pharmaceuticals market with five year forecasts by both value and volume
- What was the size of the Brazil pharmaceuticals market by value in 2022?
- What will be the size of the Brazil pharmaceuticals market in 2027?
- What factors are affecting the strength of competition in the Brazil pharmaceuticals market?
- How has the market performed over the last five years?
- What are the main segments that make up Brazil's pharmaceuticals market?
1 EXECUTIVE SUMMARY
1.1. Market value
1.2. Market value forecast
1.3. Geography segmentation
1.4. Market rivalry
1.5. Competitive landscape
2 MARKET OVERVIEW
2.1. Market definition
2.2. Market analysis
3 MARKET DATA
3.1. Market value
4 MARKET SEGMENTATION
4.1. Geography segmentation
5 MARKET OUTLOOK
5.1. Market value forecast
6 FIVE FORCES ANALYSIS
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 COMPETITIVE LANDSCAPE
7.1. Who are the leading players?
7.2. What are the strengths of leading players?
7.3. What strategies do leading players follow?
8 COMPANY PROFILES
8.1. Sanofi SA
8.2. Ache Laboratorios Farmaceuticos SA
8.3. EMS Sigma Pharma
9 MACROECONOMIC INDICATORS
9.1. Country data
10 APPENDIX
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
1.1. Market value
1.2. Market value forecast
1.3. Geography segmentation
1.4. Market rivalry
1.5. Competitive landscape
2 MARKET OVERVIEW
2.1. Market definition
2.2. Market analysis
3 MARKET DATA
3.1. Market value
4 MARKET SEGMENTATION
4.1. Geography segmentation
5 MARKET OUTLOOK
5.1. Market value forecast
6 FIVE FORCES ANALYSIS
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 COMPETITIVE LANDSCAPE
7.1. Who are the leading players?
7.2. What are the strengths of leading players?
7.3. What strategies do leading players follow?
8 COMPANY PROFILES
8.1. Sanofi SA
8.2. Ache Laboratorios Farmaceuticos SA
8.3. EMS Sigma Pharma
9 MACROECONOMIC INDICATORS
9.1. Country data
10 APPENDIX
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
LIST OF TABLES
Table 1: Brazil pharmaceuticals market value: $ billion, 2017-22
Table 2: Brazil pharmaceuticals market geography segmentation: $ billion, 2022
Table 3: Brazil pharmaceuticals market value forecast: $ billion, 2022-27
Table 4: Sanofi SA: key facts
Table 5: Sanofi SA: Annual Financial Ratios
Table 6: Sanofi SA: Key Employees
Table 7: Sanofi SA: Key Employees Continued
Table 8: Ache Laboratorios Farmaceuticos SA: key facts
Table 9: Ache Laboratorios Farmaceuticos SA: Key Employees
Table 10: EMS Sigma Pharma: key facts
Table 11: EMS Sigma Pharma: Key Employees
Table 12: Brazil size of population (million), 2018-22
Table 13: Brazil gdp (constant 2005 prices, $ billion), 2018-22
Table 14: Brazil gdp (current prices, $ billion), 2018-22
Table 15: Brazil inflation, 2018-22
Table 16: Brazil consumer price index (absolute), 2018-22
Table 17: Brazil exchange rate, 2018-22
Table 1: Brazil pharmaceuticals market value: $ billion, 2017-22
Table 2: Brazil pharmaceuticals market geography segmentation: $ billion, 2022
Table 3: Brazil pharmaceuticals market value forecast: $ billion, 2022-27
Table 4: Sanofi SA: key facts
Table 5: Sanofi SA: Annual Financial Ratios
Table 6: Sanofi SA: Key Employees
Table 7: Sanofi SA: Key Employees Continued
Table 8: Ache Laboratorios Farmaceuticos SA: key facts
Table 9: Ache Laboratorios Farmaceuticos SA: Key Employees
Table 10: EMS Sigma Pharma: key facts
Table 11: EMS Sigma Pharma: Key Employees
Table 12: Brazil size of population (million), 2018-22
Table 13: Brazil gdp (constant 2005 prices, $ billion), 2018-22
Table 14: Brazil gdp (current prices, $ billion), 2018-22
Table 15: Brazil inflation, 2018-22
Table 16: Brazil consumer price index (absolute), 2018-22
Table 17: Brazil exchange rate, 2018-22
LIST OF FIGURES
Figure 1: Brazil pharmaceuticals market value: $ billion, 2017-22
Figure 2: Brazil pharmaceuticals market geography segmentation: % share, by value, 2022
Figure 3: Brazil pharmaceuticals market value forecast: $ billion, 2022-27
Figure 4: Forces driving competition in the pharmaceuticals market in Brazil, 2022
Figure 5: Drivers of buyer power in the pharmaceuticals market in Brazil, 2022
Figure 6: Drivers of supplier power in the pharmaceuticals market in Brazil, 2022
Figure 7: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Brazil, 2022
Figure 8: Factors influencing the threat of substitutes in the pharmaceuticals market in Brazil, 2022
Figure 9: Drivers of degree of rivalry in the pharmaceuticals market in Brazil, 2022
Figure 1: Brazil pharmaceuticals market value: $ billion, 2017-22
Figure 2: Brazil pharmaceuticals market geography segmentation: % share, by value, 2022
Figure 3: Brazil pharmaceuticals market value forecast: $ billion, 2022-27
Figure 4: Forces driving competition in the pharmaceuticals market in Brazil, 2022
Figure 5: Drivers of buyer power in the pharmaceuticals market in Brazil, 2022
Figure 6: Drivers of supplier power in the pharmaceuticals market in Brazil, 2022
Figure 7: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Brazil, 2022
Figure 8: Factors influencing the threat of substitutes in the pharmaceuticals market in Brazil, 2022
Figure 9: Drivers of degree of rivalry in the pharmaceuticals market in Brazil, 2022
